Relafen 750, containing naproxen sodium, presents a complex case from a biochemical point of view . Its mechanism of action involves suppressing cyclooxygenase (COX) enzymes, specifically COX-2, which results in a decrease of prostaglandin formation. This biochemical process directly impacts inflammation and pain perception, highlighting its role a